China Medical System Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

China Medical System Holdings heeft een totaal eigen vermogen van CN¥16.0B en een totale schuld van CN¥1.1B, wat de schuld-eigenvermogensverhouding op 6.9% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥18.1B en CN¥2.2B. De EBIT China Medical System Holdings is CN¥1.7B waardoor de rentedekking -12.6 is. Het heeft contanten en kortetermijnbeleggingen van CN¥6.0B.

Belangrijke informatie

6.9%

Verhouding schuld/eigen vermogen

CN¥1.11b

Schuld

Rente dekkingsratio	-12.6x
Contant	CN¥6.04b
Aandelen	CN¥15.97b
Totaal verplichtingen	CN¥2.18b
Totaal activa	CN¥18.15b

Recente financiële gezondheidsupdates

Recent updates

Earnings Tell The Story For China Medical System Holdings Limited (HKG:867) As Its Stock Soars 26%

Sep 30

Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings

Jul 15

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

May 22

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

May 03

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

May 02

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 19

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Mar 29

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

Mar 28

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

Dec 21

Is China Medical System Holdings (HKG:867) A Risky Investment?

Dec 04

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Nov 15

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

Aug 31

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Aug 30

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

Aug 07

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

May 14

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Apr 26

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

Feb 05

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

Dec 26

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Dec 08

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Sep 14

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

Aug 25

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

Aug 15

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued

Jul 08

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

May 16

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Apr 10

China Medical System Holdings (HKG:867) Is Increasing Its Dividend To HK$0.28

Mar 22

If You Like EPS Growth Then Check Out China Medical System Holdings (HKG:867) Before It's Too Late

Feb 09

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Dec 25

Should You Be Adding China Medical System Holdings (HKG:867) To Your Watchlist Today?

Nov 10

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Sep 25

China Medical System Holdings' (HKG:867) Dividend Will Be Increased To HK$0.32

Aug 26

Here's Why We Think China Medical System Holdings (HKG:867) Is Well Worth Watching

Jul 30

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 33% Undervalued

Jun 27

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

Jun 14

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥8.8B ) 867 } overtreffen de korte termijn passiva ( CN¥2.0B ).

Langlopende schulden: De kortetermijnactiva 867 ( CN¥8.8B ) overtreffen de langetermijnschulden ( CN¥128.4M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 867 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 867 is de afgelopen 5 jaar gedaald van 15.6% naar 6.9%.

Schuldendekking: De schuld van 867 wordt goed gedekt door de operationele kasstroom ( 170.3% ).

Rentedekking: 867 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

China Medical System Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is China Medical System Holdings (HKG:867) A Risky Investment?

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Does China Medical System Holdings (HKG:867) Have A Healthy Balance Sheet?

Recent updates

Insufficient new directors

Investor sentiment improves as stock rises 20%

Earnings Tell The Story For China Medical System Holdings Limited (HKG:867) As Its Stock Soars 26%

China Medical System Holdings Limited Announces New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China

Founder recently bought HK$3.6m worth of stock

First half dividend of HK$0.16 announced

First half 2024 earnings released: EPS: CN¥0.37 (vs CN¥0.78 in 1H 2023)

China Medical System Holdings Limited Announces Re-Designation of Directors

New minor risk - Profit margin trend

China Medical System Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2024, Payable on About 9 September 2024

China Medical System Holdings Limited Announces NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

China Medical System Holdings Limited to Report First Half, 2024 Results on Aug 15, 2024

Little Excitement Around China Medical System Holdings Limited's (HKG:867) Earnings

China Medical System Holdings Limited Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China

China Medical System Holdings Limited Announces Approval of Lumeblue® by NMPA for Enhanced Colorectal Lesion Detection

Now 20% undervalued after recent price drop

Founder recently bought HK$6.8m worth of stock

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 20% Undervalued

Now 20% undervalued after recent price drop

China Medical System Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

We Think Shareholders May Want To Consider A Review Of China Medical System Holdings Limited's (HKG:867) CEO Compensation Package

Now 21% undervalued after recent price drop

China Medical System Holdings Limited Announces New Drug Application of Desidustat Tablets Accepted in China

China Medical System Holdings' (HKG:867) Shareholders Will Receive A Smaller Dividend Than Last Year

Now 21% undervalued after recent price drop

Consensus revenue estimates decrease by 18%

China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024

China Medical System Holdings (HKG:867) Is Paying Out Less In Dividends Than Last Year

Final dividend of HK$0.086 announced

Not Many Are Piling Into China Medical System Holdings Limited (HKG:867) Stock Yet As It Plummets 35%

China Medical System Holdings Limited, Annual General Meeting, May 09, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Now 38% undervalued after recent price drop

China Medical System Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on About 23 May 2024

China Medical System Holdings Limited Announces Approval to Conduct A Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Atopic Dermatitis in China

China Medical System Holdings Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

China Medical System Holdings Limited's (HKG:867) Share Price Not Quite Adding Up

China Medical System Holdings Limited Announces Approval to Conduct a Phase 3 Clinical Trial Investigating Ruxolitinib Cream in Vitiligo in China

China Medical System Holdings Limited Announces That on 4 December 2023, the New Drug Application (Nda) for an Additional Indication of Methotrexate Injection Has Been Accepted by the National Medical Products Administration of China

Is China Medical System Holdings (HKG:867) A Risky Investment?

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Upcoming dividend of HK$0.34 per share at 5.1% yield

China Medical System Holdings (HKG:867) Will Pay A Larger Dividend Than Last Year At CN¥0.342

First half 2023 earnings released: EPS: CN¥0.78 (vs CN¥0.73 in 1H 2022)

China Medical System Holdings (HKG:867) Could Easily Take On More Debt

China Medical System Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on September 20, 2023

China Medical System Holdings Limited to Report First Half, 2023 Results on Aug 28, 2023

Here's Why We Think China Medical System Holdings (HKG:867) Might Deserve Your Attention Today

China Medical System Holdings Limited Receives Approval from National Medical Products Administration of China for New Drug Application of Diazepam Nasal Spray

National Medical Products Administration of China Approves China Medical System Holdings's New Drug Application of Tildrakizumab Injection under the Brand Name of ILUMETRI

We Think China Medical System Holdings (HKG:867) Can Manage Its Debt With Ease

Upcoming dividend of HK$0.27 per share at 4.5% yield

Does China Medical System Holdings (HKG:867) Deserve A Spot On Your Watchlist?

Full year 2022 earnings released: EPS: CN¥1.33 (vs CN¥1.22 in FY 2021)

China Medical System Holdings Limited Announces New Drug Application of Methylthioninium Chloride Enteric-Coated Sustained-Release Tablets

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 47% Undervalued

China Medical System Holdings (HKG:867) Seems To Use Debt Rather Sparingly

China Medical System Holdings Limited Announces its Methylthioninium Chloride Enteric-Coated Sustained-Release Tablets Obtains Positive Results for its Phase III Clinical Trial in China

If EPS Growth Is Important To You, China Medical System Holdings (HKG:867) Presents An Opportunity

Investor sentiment improved over the past week

Is China Medical System Holdings (HKG:867) Using Too Much Debt?

Upcoming dividend of HK$0.34 per share

China Medical System Holdings (HKG:867) Is Paying Out A Larger Dividend Than Last Year

First half 2022 earnings released: EPS: CN¥0.73 (vs CN¥0.66 in 1H 2021)

China Medical System Holdings Limited Announces Interim Dividend for the Six Months Ended June 30, 2022, Payable on 15 September 2022

Do China Medical System Holdings' (HKG:867) Earnings Warrant Your Attention?

China Medical System Holdings Limited to Report First Half, 2022 Results on Aug 22, 2022

An Intrinsic Calculation For China Medical System Holdings Limited (HKG:867) Suggests It's 49% Undervalued